| | | Morningstar Overall Rating: |  | | Total Assets: | 124.85M | | Category: | Health | | Total Expense Ratio: | % |
|
| PERFORMANCE & RISK | 30-Nov-09 |
| YTD Return: | 16.56% | | 5y Avg Return: | 4.10% | | Rank in Category (ytd): | 97 | | % Rank in Category (ytd): | 58.79% | | Beta (3y): | 0.74 | | Morningstar Risk Rating: | Average |
|
| The investment seeks capital appreciation. The fund normally invests at least 80% of assets in common stocks (including depositary receipts) of health science companies throughout the world. It may invest up to 50% of net assets in foreign securities, including emerging-market securities. The fund may also use derivative instrucments. | | | Fund Profile |
|
Help
0.07 (0.56%) 
Summary
Add HCRAX to Portfolio 
Download Data
